Heparin Sodium
Heparin Sodium
15 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 20 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Heparin Sodium
Average across 20 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi, USA LLC | generic | 20 | SUPPLYING |
| Hospira, Inc. | brand | 14 | SUPPLYING |
| Sagent Pharmaceuticals | generic | 12 | SUPPLYING |
| Hepalink USA Inc. | unknown | 9 | SUPPLYING |
| Sandoz Inc | generic | 9 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 7 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 6 | SUPPLYING |
| Baxter Healthcare Corporation | brand | 4 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 3 | SUPPLYING |
| Henry Schein, Inc. | relabeler | 2 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | generic | 2 | SUPPLYING |
| BE Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 2 | SUPPLYING |
| Phlow Corporation | unknown | 1 | SUPPLYING |
| McKesson Corporation dba SKY Packaging | unknown | 0 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. — Recalling firm: Baxter Healthcare Corporation — Nationwide in the USA
Lack of assurance of sterility: Bags have the potential to leak. — Recalling firm: Pfizer Inc. — Nationwide in the USA.
Heparin Sodium Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Hematology.
Heparin Sodium Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Hematology.
Subpotent Drug; out of specification results for heparin raw material — Recalling firm: Baxter Healthcare Corp — Nationwide
Subpotent Drug: Heparin raw material was found to have low potency — Recalling firm: Baxter Healthcare Corp. — Nationwide
Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container. — Recalling firm: Hospira Inc. — Nationwide
Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag. — Recalling firm: Hospira Inc. — Nationwide
Subpotent; 18 month time point — Recalling firm: Fresenius Kabi USA, LLC — Nationwide
Lack of Assurance of Sterility; potential leakage from administrative port. — Recalling firm: Hospira Inc. — Nationwide including Puerto Rico
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port. — Recalling firm: Baxter Healthcare Corp. — Nationwide & Puerto Rico